| Product |
CAS |
Molecular formula |
More |
| 1-Piperidinecarbothioamide,n-(2-methoxyethyl)-2,6-dimethyl-(9ci) |
827591-72-0 |
C11H22N2OS |
More |
| 1-Piperidinecarbothioamide,n-(2-methoxyphenyl)-3-(5-methyl-1h-benzimid |
606090-16-8 |
C21H24N4OS |
More |
| 1-Piperidinecarbothioamide,n-(2-methyl-2-propenyl)-(9ci) |
452317-74-7 |
C10H18N2S |
More |
| 1-Piperidinecarbothioamide,n-(3,4-dimethylphenyl)-3-(5-methyl-1h-benzi |
606090-26-0 |
|
More |
| 1-Piperidinecarbothioamide,n-(3,5-dimethylphenyl)-3-(5-methyl-1h-benzi |
606090-27-1 |
C22H26N4S |
More |
| 1-Piperidinecarbothioamide,n-(3-chlorophenyl)-3-(5,6-dimethyl-1h-benzi |
606089-40-1 |
C21H23ClN4S |
More |
| 1-Piperidinecarbothioamide,n-(3-chlorophenyl)-3-(5-methyl-1h-benzimida |
606090-21-5 |
|
More |
| 1-Piperidinecarbothioamide,n-(3-ethoxypropyl)-3-(5-methyl-1h-benzimida |
606090-06-6 |
C19H28N4OS |
More |
| 1-Piperidinecarbothioamide,n-(3-methoxyphenyl)-3-(5-methyl-1h-benzimid |
606090-17-9 |
C21H24N4OS |
More |
| 1-Piperidinecarbothioamide,n-(3-methoxypropyl)-3-(5-methyl-1h-benzimid |
606090-05-5 |
C18H26N4OS |
More |
| 1-Piperidinecarbothioamide,n-(4-chlorophenyl)-3-(5,6-dimethyl-1h-benzi |
606089-34-3 |
|
More |
| 1-Piperidinecarbothioamide,n-(4-chlorophenyl)-3-(5-methyl-1h-benzimida |
606090-15-7 |
|
More |
| 1-Piperidinecarbothioamide,n-(4-ethoxyphenyl)-3-(5-methyl-1h-benzimida |
606090-20-4 |
C22H26N4OS |
More |
| 1-Piperidinecarbothioamide,n-(4-ethylphenyl)-3-(5-methyl-1h-benzimidaz |
606090-13-5 |
|
More |
| 1-Piperidinecarbothioamide,n-(4-fluorophenyl)-3-(5-methyl-1h-benzimida |
606090-22-6 |
|
More |
| 1-Piperidinecarbothioamide,n-(4-methoxyphenyl)-3-(5-methyl-1h-benzimid |
606090-18-0 |
C21H24N4OS |
More |
| 1-Piperidinecarbothioamide,n-2-propenyl-(9ci) |
444082-02-4 |
C9H16N2S |
More |
| 1-Piperidinecarbothioamide,n-butyl-(9ci) |
452948-70-8 |
C10H20N2S |
More |
| 1-Piperidinecarbothioamide,n-cyclohexyl-3-(5,6-dimethyl-1h-benzimidazo |
606089-26-3 |
|
More |
| 1-Piperidinecarbothioamide,n-cyclohexyl-3-(5-methyl-1h-benzimidazol-2- |
606090-07-7 |
|
More |
